Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Egbert Oosterwijk

Showing results (121-130 of 190) with videos related to

Pageof 19
Sort By:
Laboratory Animals|September 27, 2017
Clinical protocol levels are required in laboratory animal surgery when using medical devices: experiences with ureteral replacement surgery in goatsPaul K J D de Jonge, Marije Sloff, Heinz P Janke, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2003
Pretargeting with labeled bivalent peptides allowing the use of four radionuclides: (111)In, (131)I, (99m)Tc, and (188)ReFrank G van Schaijk, Egbert Oosterwijk, Annemiele C Soede, et al.
Pharmaceutics|November 27, 2021
Mimicking the Biology of Engineered Protein and mRNA Nanoparticle Delivery Using a Versatile Microfluidic PlatformValentina Palacio-Castañeda, Rik Oude Egberink, Arbaaz Sait, et al.
Tissue Engineering. Part C, Methods|April 18, 2023
Comparison of Osteogenic Capacity and Osteoinduction of Adipose Tissue-Derived Cell PopulationsJohanna F A Husch, Laura Coquelin, Nathalie Chevallier, et al.
Neoplasia (New York, N.Y.)|July 25, 2022
Combination of sunitinib and <sup>177</sup>Lu-labeled antibody cG250 targeted radioimmunotherapy: A promising new therapeutic strategy for patients with advanced renal cell cancerJeannette C Oosterwijk-Wakka, Mirjam C A de Weijert, Gerben M Franssen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 8, 2005
Pretargeting with bispecific anti-renal cell carcinoma x anti-DTPA(In) antibody in 3 RCC modelsFrank G van Schaijk, Egbert Oosterwijk, Janneke D Molkenboer-Kuenen, et al.
Molecular Pharmaceutics|August 23, 2017
Improved Intraoperative Detection of Ovarian Cancer by Folate Receptor Alpha Targeted Dual-Modality ImagingMarlène C H Hekman, Otto C Boerman, Desirée L Bos, et al.
Plos One|November 5, 2014
Enhanced cellular uptake of albumin-based lyophilisomes when functionalized with cell-penetrating peptide TAT in HeLa cellsEtienne van Bracht, Luuk R M Versteegden, Sarah Stolle, et al.
European Urology|April 8, 2017
Tissue Engineering of the Urethra: A Systematic Review and Meta-analysis of Preclinical and Clinical StudiesLuuk R M Versteegden, Paul K J D de Jonge, Joanna IntHout, et al.
Pharmaceuticals (Basel, Switzerland)|May 28, 2022
Carbonic Anhydrase IX-Targeted α-Radionuclide Therapy with 225Ac Inhibits Tumor Growth in a Renal Cell Carcinoma ModelRobin I J Merkx, Mark Rijpkema, Gerben M Franssen, et al.
Pageof 19

Showing results (121-130 of 190) with videos related to

Sort By:
Pageof 19
Laboratory Animals|September 27, 2017
Clinical protocol levels are required in laboratory animal surgery when using medical devices: experiences with ureteral replacement surgery in goatsPaul K J D de Jonge, Marije Sloff, Heinz P Janke, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2003
Pretargeting with labeled bivalent peptides allowing the use of four radionuclides: (111)In, (131)I, (99m)Tc, and (188)ReFrank G van Schaijk, Egbert Oosterwijk, Annemiele C Soede, et al.
Pharmaceutics|November 27, 2021
Mimicking the Biology of Engineered Protein and mRNA Nanoparticle Delivery Using a Versatile Microfluidic PlatformValentina Palacio-Castañeda, Rik Oude Egberink, Arbaaz Sait, et al.
Tissue Engineering. Part C, Methods|April 18, 2023
Comparison of Osteogenic Capacity and Osteoinduction of Adipose Tissue-Derived Cell PopulationsJohanna F A Husch, Laura Coquelin, Nathalie Chevallier, et al.
Neoplasia (New York, N.Y.)|July 25, 2022
Combination of sunitinib and <sup>177</sup>Lu-labeled antibody cG250 targeted radioimmunotherapy: A promising new therapeutic strategy for patients with advanced renal cell cancerJeannette C Oosterwijk-Wakka, Mirjam C A de Weijert, Gerben M Franssen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 8, 2005
Pretargeting with bispecific anti-renal cell carcinoma x anti-DTPA(In) antibody in 3 RCC modelsFrank G van Schaijk, Egbert Oosterwijk, Janneke D Molkenboer-Kuenen, et al.
Molecular Pharmaceutics|August 23, 2017
Improved Intraoperative Detection of Ovarian Cancer by Folate Receptor Alpha Targeted Dual-Modality ImagingMarlène C H Hekman, Otto C Boerman, Desirée L Bos, et al.
Plos One|November 5, 2014
Enhanced cellular uptake of albumin-based lyophilisomes when functionalized with cell-penetrating peptide TAT in HeLa cellsEtienne van Bracht, Luuk R M Versteegden, Sarah Stolle, et al.
European Urology|April 8, 2017
Tissue Engineering of the Urethra: A Systematic Review and Meta-analysis of Preclinical and Clinical StudiesLuuk R M Versteegden, Paul K J D de Jonge, Joanna IntHout, et al.
Pharmaceuticals (Basel, Switzerland)|May 28, 2022
Carbonic Anhydrase IX-Targeted α-Radionuclide Therapy with 225Ac Inhibits Tumor Growth in a Renal Cell Carcinoma ModelRobin I J Merkx, Mark Rijpkema, Gerben M Franssen, et al.
Pageof 19